PHILADELPHIA EAGLES RENEW DEAL WITH SELECT MEDICAL NAMING NOVACARE REHABILITATION THE TEAM'S OFFICIAL PHYSICAL THERAPY PARTNER
Rhea-AI Summary
Select Medical (NYSE:SEM) and the Philadelphia Eagles announced a multi-year extension renewing NovaCare Rehabilitation as the team's Official Physical Therapy Partner, continuing a 25-year founding partnership.
The agreement names NovaCare as a presenting sponsor for digital fan content, in-stadium signage and videoboards, radio spots, gameday notifications, and continued community involvement including the Eagles Autism Challenge.
Positive
- None.
Negative
- None.
News Market Reaction – SEM
On the day this news was published, SEM declined NaN%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
SEM is up 0.55% while peers show mixed moves: PACS down 1.84%, AVAH and ARDT up just over 1%, NHC flat, and PIII notably higher by 7%. Only one peer appears in the momentum scanner, suggesting today’s action is more company-specific than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 21 | Earnings call date | Neutral | -0.3% | Announcement of Q4 and full-year 2025 results release and call schedule. |
| Nov 24 | Take-private proposal | Positive | +2.6% | Executive Chairman’s non-binding offer at $16.00–$16.20 per share. |
| Oct 30 | Earnings and dividend | Positive | -0.6% | Q3 2025 beat-like growth with dividend and extended $1.0B buyback. |
| Oct 02 | Earnings call date | Neutral | -0.1% | Scheduling of Q3 2025 results release and investor call details. |
| Sep 02 | Leadership changes | Neutral | -0.8% | Internal CEO succession and related executive role adjustments. |
Recent news has often been followed by modest price moves, with one notable divergence on strong Q3 2025 results.
Over the past six months, Select Medical has focused on financial reporting, capital returns, leadership transitions, and a potential take‑private proposal. Q3 2025 results showed revenue of $1,363.4M and Adjusted EBITDA of $111.7M, alongside a dividend and a $1.0B repurchase authorization, yet the stock fell slightly. The non‑binding $16.00–$16.20 per‑share proposal on Nov 24, 2025 saw a positive reaction. Today’s multi‑year extension of the Eagles partnership fits into this pattern of incremental, relationship‑driven news rather than transformational events.
Market Pulse Summary
This announcement extends a multi-year partnership between Select Medical’s NovaCare Rehabilitation and the Philadelphia Eagles, building on a 25-year relationship and expanding marketing exposure and community programs. In recent months, the company has reported solid financial results, leadership transitions, and a non‑binding take‑private proposal. Investors evaluating this news may track future earnings updates, any developments on strategic alternatives, and how enhanced brand visibility contributes to sustaining SEM’s position above its 200-day MA.
AI-generated analysis. Not financial advice.
"We are proud to continue our longstanding founding partner relationship with the Philadelphia Eagles, an organization that shares our passion for excellence and creating unforgettable fan experiences," said Ray Pennacchia, senior vice president, NovaCare Rehabilitation. "Many of those fans also trust NovaCare Rehabilitation for world-class physical therapy throughout the Delaware Valley. This renewed agreement builds on 25 years of trust and performance, and we look forward to achieving even greater impact together in the seasons and years ahead."
As part of the extended agreement, NovaCare Rehabilitation will serve as the presenting sponsor of unique fan content across the team's digital platforms, including sweepstakes, post-game locker room victory speeches, gameday push notifications, and banner advertising. Additional brand exposure elements include radio spots, end zone videoboards, and rotating LED and traditional signage throughout Lincoln Financial Field during home games. NovaCare Rehabilitation will continue to be involved in community programs, such as the Eagles Autism Challenge.
"We are thrilled to extend and build upon our partnership with NovaCare Rehabilitation through this renewed, long-term commitment," said Brian Napoli, senior vice president, corporate partnerships, Philadelphia Eagles. "It has been a privilege having NovaCare by our side for the past 25 years as we proudly served the
About Select Medical and NovaCare Rehabilitation
Select Medical Corporation ("Select Medical") is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in
Media Contacts
Select Medical/NovaCare Rehabilitation: Shelly Eckenroth, seckenroth@selectmedical.com, 717-920-4035
Philadelphia Eagles: Anthony Bonagura, abonagura@eagles.nfl.com, 609-707-5877
View original content:https://www.prnewswire.com/news-releases/philadelphia-eagles-renew-deal-with-select-medical-naming-novacare-rehabilitation-the-teams-official-physical-therapy-partner-302688772.html
SOURCE Select Medical Holdings Corporation
FAQ
What did Select Medical (SEM) announce about NovaCare Rehabilitation on February 17, 2026?
How will the NovaCare Rehabilitation partnership affect Eagles game-day exposure for Select Medical (SEM)?
Will NovaCare Rehabilitation remain involved in community programs with the Philadelphia Eagles after the SEM deal?
What digital marketing elements are included in the Select Medical (SEM) and Eagles partnership renewal?
Why did Select Medical emphasize the 25-year history with the Philadelphia Eagles in the renewal (SEM)?
